Nuvasive Profit Margin

Nuvasive (NUVA) currently reports a profit margin of 2.32% as of June 2023. That compares with -3.41% in the prior-year period — up 168.0% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Nuvasive's profit margin history and peer comparisons.

Nuvasive's profit margin increased from -3.41% to 2.32% — a 168.0% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nuvasive's profit margin of 2.32% is lower than the Healthcare sector average of 15.58%. That is roughly 85.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nuvasive's current 2.32% should be judged against Healthcare norms (sector average: 15.58%) and against NUVA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 2.32%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Nuvasive, and consider following NUVA for alerts when major investors trade the stock.